New WHO guideline on treating MNS disorders
It is estimated that more than 75% of people with MNS disorders are unable to access the treatment or care they need.
PREMIUM Health
The updated WHO guideline includes advice against the use of valproic acid (sodium valproate) due to risk of birth defects if taken during pregnancy. (AFP)
By NewVision Reporter
Journalists @NewVision
_________________________
In its third edition of the Mental Health Gap Action Programme, the World Health Organization (WHO) has included "important new and updated" recommendations for the treatment